Mercer Global Advisors Inc Haemonetics Corp Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Mercer Global Advisors Inc holds 3,919 shares of HAE stock, worth $335,270. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,919

Previous 5,941 34.03%

Holding current value

$335,270

Previous $491,000 36.05%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$72.45 - $91.58 $146,493 - $185,174	-2,022 Reduced 34.03%	3,919 $314,000
Q2 2024 Aug 12, 2024	BUY	$81.24 - $97.37 $139,570 - $167,281	1,718 Added 40.68%	5,941 $491,000
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $29,350 - $35,164	-412 Reduced 8.89%	4,223 $360,000
Q4 2023 Feb 14, 2024	SELL	$80.59 - $92.61 $4,271 - $4,908	-53 Reduced 1.13%	4,635 $396,000
Q3 2023 Nov 13, 2023	BUY	$82.56 - $93.49 $12,218 - $13,836	148 Added 3.26%	4,688 $420,000
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $28,940 - $32,023	358 Added 8.56%	4,540 $386,000
Q1 2023 May 15, 2023	BUY	$72.75 - $90.6 $23,207 - $28,901	319 Added 8.26%	4,182 $346,000
Q4 2022 Feb 08, 2023	SELL	$73.85 - $86.14 $81,678 - $95,270	-1,106 Reduced 22.26%	3,863 $304,000
Q3 2022 Nov 15, 2022	SELL	$63.3 - $78.66 $6,203 - $7,708	-98 Reduced 1.93%	4,969 $368,000
Q2 2022 Aug 10, 2022	BUY	$49.27 - $66.08 $249,651 - $334,827	5,067 New	5,067 $330,000
Q3 2021 Nov 10, 2021	SELL	$57.6 - $70.59 $275,385 - $337,490	-4,781 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$51.81 - $118.56 $58,856 - $134,684	-1,136 Reduced 19.2%	4,781 $319,000
Q1 2021 May 11, 2021	BUY	$111.01 - $139.48 $431,606 - $542,298	3,888 Added 191.62%	5,917 $657,000
Q1 2019 Apr 12, 2019	BUY	$83.25 - $102.12 $168,914 - $207,201	2,029 New	2,029 $203,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.39B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Haemonetics Corp Transaction History